Logo wahanariau.com
  2. Zymeworks

Zymeworks

Index
Globenewswire

Zymeworks Announces Achievement of $14 Million Milestone from GSK Collaboration

Rabu, 26 Februari 2025 - 23:51:40 Wib
Globenewswire

Zymeworks To Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on March 5, 2025

Kamis, 13 Februari 2025 - 21:16:56 Wib
Globenewswire

Zymeworks Outlines Strategic Priorities and Outlook for 2025 and 2026

Kamis, 09 Januari 2025 - 05:00:00 Wib
Globenewswire

Zymeworks Hosts R&D Day Highlighting Continued Clinical Progress in Oncology Programs and Expansion into Autoimmune and Inflammatory Diseases

Kamis, 12 Desember 2024 - 21:00:00 Wib
Globenewswire

Zymeworks Announces Participation in Upcoming Investor Conferences-

Kamis, 21 November 2024 - 18:30:00 Wib
Globenewswire

FDA Grants U.S. Approval of Ziihera® (zanidatamab-hrii) for the Treatment of Adults with Previously Treated, Unresectable or Metastatic HER2-positive (IHC 3+) Biliary Tract Cancer (BTC)

Kamis, 21 November 2024 - 18:30:00 Wib
Globenewswire

Zymeworks Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating ZW191 in Folate Receptor-⍺ Expressing Advanced Solid Tumors

Selasa, 05 November 2024 - 18:30:00 Wib
Globenewswire

Zymeworks Announces Participation in Upcoming Investor Conferences,

Selasa, 29 Oktober 2024 - 17:30:00 Wib
Globenewswire

Zymeworks Presents New Preclinical Data on Antibody-Drug Conjugate Programs at EORTC-NCI-AACR Conference

Jumat, 25 Oktober 2024 - 17:30:00 Wib
Globenewswire

Zymeworks Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating ZW171 in Advanced Mesothelin-Expressing Cancers

Senin, 21 Oktober 2024 - 17:30:00 Wib
Globenewswire

Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate Programs at EORTC-NCI-AACR Conference

Rabu, 18 September 2024 - 17:30:00 Wib
Globenewswire

Zymeworks Announces Share Repurchase Program of up to $60 Million of its Common Stock

Jumat, 02 Agustus 2024 - 11:06:22 Wib
Globenewswire

Zymeworks Appoints Leone Patterson as Chief Business and Financial Officer

Jumat, 26 Juli 2024 - 09:13:22 Wib
Globenewswire

Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW191, a Novel Folate Receptor-⍺ Targeted Topoisomerase I Inhibitor Antibody-Drug Conjugate

Senin, 22 Juli 2024 - 17:30:00 Wib
Globenewswire

Zymeworks To Report Second Quarter 2024 Financial Results and Host Conference Call on August 1, 2024

Kamis, 11 Juli 2024 - 18:00:00 Wib
Globenewswire

Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW171, a novel 2+1 T-cell Targeting Bispecific Antibody for Mesothelin-expressing Cancers

Selasa, 18 Juni 2024 - 05:05:38 Wib
Globenewswire

Zymeworks Announces China NMPA Acceptance of Biologics License Application for Zanidatamab for Second-Line Treatment of Biliary Tract Cancer

Selasa, 11 Juni 2024 - 05:59:21 Wib
Globenewswire

Zymeworks Announces Participation in Upcoming Investor Conferences....

Rabu, 29 Mei 2024 - 21:55:35 Wib
Globenewswire

Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results

Sabtu, 04 Mei 2024 - 06:43:34 Wib
Globenewswire

Zymeworks Announces Participation in Upcoming Investor Conferences...

Rabu, 01 Mei 2024 - 03:16:03 Wib
Globenewswire

Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors

Jumat, 29 Maret 2024 - 05:07:42 Wib
Globenewswire

Zymeworks Announces Participation in Upcoming Investor Conferences..

Kamis, 28 Maret 2024 - 07:53:02 Wib
Globenewswire

Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate and Multispecific Platforms at the American Association for Cancer Research Annual Meeting

Kamis, 07 Maret 2024 - 04:49:21 Wib
Globenewswire

Zymeworks Announces Participation in Upcoming Investor Conferences.

Rabu, 28 Februari 2024 - 05:08:10 Wib
Globenewswire

Zymeworks Announces Appointment of Dr. Alessandra Cesano to its Board of Directors

Kamis, 08 Februari 2024 - 18:30:00 Wib